| Literature DB >> 36128376 |
Bing-Wen Zhang1, Li Jiang1, Zhuang Li1, Xue-Hui Gao1, Fei Cao1, Xin-Hua Lu2, Wen-Bin Shen2, Xue-Xia Zhang2, Fan-Dong Kong3, Du-Qiang Luo1.
Abstract
Seven undescribed carotane sesquiterpenoids named fusanoids A-G (1-7), along with one known analog (8) and two known sesterterpenes (9 and 10), were isolated from the fermentation broth of the desert endophytic fungi Fusarium sp. HM166. The structures of the compounds, including their absolute configurations, were determined by spectroscopic data, single-crystal X-ray diffraction analysis, and ECD calculations. Compound 10 showed cytotoxic activities against human hepatoma carcinoma cell line (Huh-7) and human breast cell lines (MCF-7 and MDA-MB-231), and compound 2 showed cytotoxic activity against MCF-7, while compounds 4-9 were inactive against all the tested cell lines. Compounds 4 and 10 showed potent inhibitory activities against the IDH1R132h mutant. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 36128376 PMCID: PMC9428550 DOI: 10.1039/d2ra02762c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Structures of compounds 1–10.
The 1H NMR data for 1–7
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| 1a | 1.31, overlap | 1.31, m | 1.43, overlap | 1.72, overlap | 3.51, dd (6.6, 11.2) | 1.58, m | 1.30, overlap |
| 1b | 1.66, m | 1.47, m | 1.48, overlap | 1.74, overlap | 1.79, m | 1,44, overlap | |
| 2a | 1.33, overlap | 1.43, m | 1.57, overlap | 1.40, m | 1.39, m | 1.47, m | 1.69, m |
| 2b | 1.74, overlap | 1.68, m | 1.79, overlap | 1.77, m | 1.93, m | 1.75, m | 1.48, m |
| 3 | 2.43, m | 2.34, m | 2.42, overlap | 2.34, m | 2.25, overlap | 2.46, m | 2.30, m |
| 4 | 1.82, m | 1.85, ddd (12.3, 12.3, 2.7) | 1.98, m | 2.41, m | 1.87, dd (11.6, 12.5) | 2.47, m | 1.88, ddd (3.9, 12.5, 13.4) |
| 6a | 3.86, br s | 1.38, dd (11.7, 11.7) | 2.54, d (14.5) | 1.67, br d (13.8) | 3.88, s | 1.23, dd (10.3, 13.1) | |
| 6b | 1.96, dd (4.1, 11.7) | 2.48, d (14.5) | 2.21, overlap | 2.11, dd (6.4, 13.1) | |||
| 7 | 5.25, br s | 4.28, br d (11.7) | 5.81, s | 5.40, m | 4.17, dd (6.4, 10.3) | ||
| 8 | 2.48, overlap | ||||||
| 9a | 1.89, m | 5.54, d (8.1) | 1.44, overlap | 2.28, m | 2.09, m | 6.50, br d (7.4) | 2.23, m |
| 9b | 2.06, m | 1.93, m | 2.41, m | 1.96, m | 2.29, m | ||
| 10a | 1.42, m | 2.15, m | 1.72, m | 2.02, m | 2.26, m | 3.17, m | 1.57, m |
| 10b | 2.33, m | 2.81, ddd (2.7, 8.6, 16.8) | 2.57, m | 2.56, m | 1.53, m | 2.50, m | 2.39, m |
| 11a | 1.74, s | 1.76, s | 1.08,d (7.2) | 1.89, s | 1.73, s | 1.88, s | 4.88, br s |
| 11b | 5.04, br s | ||||||
| 13 | 0.80, s | 0.93, s | 0.97, s | 1.16, s | 0.72, s | 0.77, s | 0.91, s |
| 14 | 1.14, s | 1.16, s | 1.19, s | 1.25, s | 1.14, s | 1.23, s | 1.16, s |
| 15 | 1,17, s | 1.18, s | 1.22, s | 1.27, s | 1.18, s | 1.24, s | 1.19, s |
1H (600 MHz) NMR data in CD3OD.
1H (600 MHz) NMR data in CDCl3.
The 13C NMR data for 1–7
| Position | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| 1 | 39.4, CH2 | 43.3, CH2 | 43.1, CH2 | 35.8, CH2 | 79.9, CH | 39.6, CH2 | 43.8, CH2 |
| 2 | 27.8, CH2 | 28.0, CH2 | 28.4, CH2 | 27.0, CH2 | 35.8, CH2 | 28.0, CH2 | 28.2, CH2 |
| 3 | 54.2, CH | 53.9, CH | 53.5, CH | 52.1, CH | 49.0, CH | 54.0, CH | 54.0, CH |
| 4 | 55.2, CH | 51.5, CH | 56.1, CH | 44.3, CH | 55.8, CH | 49.1, CH | 53.1, CH |
| 5 | 48.8, C | 43.4, C | 42.3, C | 56.3, C | 45.4, C | 47.5, C | 43.9, C |
| 6 | 81.5, CH | 52.5, CH2 | 58.1, CH2 | 208.0, C | 40.8, CH2 | 87.3, CH | 51.5, CH2 |
| 7 | 131.7, CH | 70.6, CH | 218.6, C | 127.1, C | 123.5, CH | 204.3, C | 74.1, CH |
| 8 | 136.6, C | 141.4, C | 48.4, CH | 152.2, C | 140.6, C | 134.9, C | 155.0, C |
| 9 | 36.9, CH2 | 126.3, CH | 27.1, CH2 | 35.5, CH2 | 37.0, CH2 | 143.4, CH | 34.0, CH2 |
| 10 | 24.1, CH2 | 27.8, CH2 | 18.9, CH3 | 22.8, CH2 | 24.3, CH2 | 29.9, CH2 | 27.7, CH2 |
| 11 | 27.1, CH3 | 23.5, CH3 | 74.1, C | 28.3, CH3 | 27.4, CH3 | 21.9, CH3 | 113.1, CH2 |
| 12 | 75.0, C | 74.8, C | 21.2, CH3 | 73.9, C | 74.8, C | 74.3, C | 74.6, C |
| 13 | 14.4, CH3 | 18.9, CH3 | 11.1, CH3 | 20.1, CH3 | 13.5, CH3 | 14.0, CH3 | 19.7, CH3 |
| 14 | 32.3, CH3 | 32.4, CH3 | 32.1, CH3 | 32.5, CH3 | 32.1, CH3 | 32.9, CH3 | 32.0, CH3 |
| 15 | 26.8, CH3 | 27.2, CH3 | 27.3, CH3 | 27.2, CH3 | 27.1, CH3 | 27.1, CH3 | 27.7, CH3 |
13C (150 MHz) NMR data in CD3OD.
13C (150 MHz) NMR data in CDCl3.
Fig. 2Key 1H–1H and HMBC correlations of 1.
Fig. 3Key ROESY correlations of 1.
Fig. 5Calculated and experimental ECD spectra of 1.
Fig. 4ORTEP drawing of compound 1.